Companies that reported the most in general payments in 2025

Download CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.

• BioNTech SE 13.7% of the year $536,410,036 · 147 payments
• AbbVie, Inc. 5.1% of the year $201,690,737 · 1,682,658 payments
• Stryker Corporation 3.4% of the year $133,465,720 · 212,944 payments
• Medtronic, Inc. 2.9% of the year $111,704,211 · 346,536 payments
• Arthrex, Inc. 2.7% of the year $106,092,053 · 46,235 payments
• Boston Scientific Corporation 2.6% of the year $101,694,139 · 298,380 payments
• Zimmer Biomet Holdings, Inc. 2.3% of the year $88,547,398 · 38,508 payments
• Intuitive Surgical, Inc. 1.8% of the year $70,039,237 · 102,573 payments
• AstraZeneca Pharmaceuticals LP 1.8% of the year $69,553,694 · 555,048 payments
• Advanced Accelerator Applications 1.6% of the year $64,340,900 · 331 payments
• Novo Nordisk AS 1.6% of the year $61,667,715 · 825 payments
• DePuy Synthes Products, Inc. 1.6% of the year $61,515,817 · 1,893 payments
• Genzyme Corporation 1.6% of the year $61,224,697 · 204,032 payments
• Genentech, Inc. 1.3% of the year $51,407,479 · 3,254 payments
• Smith+Nephew, Inc. 1.3% of the year $51,025,923 · 72,943 payments
• Lilly USA, LLC 1.2% of the year $48,207,881 · 425,910 payments
• Takeda Pharmaceuticals U.S.A., Inc. 1.2% of the year $46,009,914 · 171,317 payments
• Amgen Inc. 1.2% of the year $45,848,289 · 504,233 payments
• Pfizer Inc. 1.1% of the year $44,497,239 · 549,896 payments
• Janssen Biotech, Inc. 1.1% of the year $42,833,201 · 384,848 payments
• Abbott Laboratories 1% of the year $39,967,014 · 265,287 payments
• E.R. Squibb & Sons, L.L.C. 1% of the year $39,312,867 · 249,310 payments
• Novo Nordisk Inc 0.9% of the year $36,753,823 · 512,725 payments
• Gilead Sciences, Inc. 0.9% of the year $36,334,798 · 124,634 payments
• Globus Medical, Inc. 0.9% of the year $36,057,394 · 55,935 payments
• Regeneron Healthcare Solutions, Inc. 0.7% of the year $29,073,374 · 186,616 payments
• Alphatec Spine, Inc 0.7% of the year $28,850,777 · 6,134 payments
• Histosonics, Inc. 0.7% of the year $25,641,082 · 1,434 payments
• Merck Sharp & Dohme Corporation 0.6% of the year $24,391,561 · 197,625 payments
• Encore Medical, LP 0.6% of the year $24,112,531 · 3,238 payments
• Align Technology, Inc. 0.6% of the year $23,775,241 · 69,799 payments
• UCB, Inc. 0.6% of the year $23,576,570 · 187,473 payments
• GlaxoSmithKline, LLC. 0.6% of the year $22,993,880 · 346,594 payments
• Novartis Pharmaceuticals Corporation 0.6% of the year $22,055,102 · 383,742 payments
• Galderma Laboratories, L.P. 0.6% of the year $21,580,645 · 116,421 payments
• Edwards Lifesciences Corporation 0.6% of the year $21,392,415 · 72,174 payments
• Axsome Therapeutics, Inc. 0.5% of the year $20,713,266 · 156,827 payments
• LivaNova USA, Inc. 0.5% of the year $20,416,551 · 8,734 payments
• Neurocrine Biosciences, Inc. 0.5% of the year $19,793,556 · 134,030 payments
• Alcon Vision LLC 0.5% of the year $19,110,503 · 112,702 payments
• AngioDynamics, Inc. 0.5% of the year $18,413,670 · 13,270 payments
• Medical Device Business Services, Inc. 0.5% of the year $18,043,854 · 27,230 payments
• CSL Plasma Inc. 0.5% of the year $17,791,826 · 17,515 payments
• ITI, Inc. 0.4% of the year $16,858,557 · 212,166 payments
• Boehringer Ingelheim Pharmaceuticals, Inc. 0.4% of the year $16,600,093 · 171,436 payments
• Bausch & Lomb Americas Inc. 0.4% of the year $15,730,087 · 86,027 payments
• Alexion Pharmaceuticals, Inc. 0.4% of the year $15,677,235 · 38,163 payments
• Madrigal Pharmaceuticals 0.4% of the year $15,600,807 · 76,204 payments
• Teva Pharmaceuticals USA, Inc. 0.4% of the year $14,918,556 · 144,567 payments
• Celgene Corporation 0.4% of the year $14,761,125 · 32,330 payments